FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR
FRA:RDC (2/21/2025, 7:00:00 PM)
114.5
-0.3 (-0.26%)
The current stock price of RDC.DE is 114.5 EUR. In the past month the price decreased by -9.13%. In the past year, price decreased by -18.68%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
W8A.DE | WALGREENS BOOTS ALLIANCE INC | 3.77 | 8.50B | ||
TALEA.MI | TALEA GROUP SPA | N/A | 42.00M |
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,075 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
REDCARE PHARMACY NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 2075
Company Website: https://shop-apotheke-europe.com/
Investor Relations: https://ir.redcare-pharmacy.com/en
The current stock price of RDC.DE is 114.5 EUR. The price decreased by -0.26% in the last trading session.
The exchange symbol of REDCARE PHARMACY NV is RDC and it is listed on the Deutsche Boerse Ag exchange.
RDC.DE stock is listed on the Deutsche Boerse Ag exchange.
19 analysts have analysed RDC.DE and the average price target is 162.03 EUR. This implies a price increase of 41.51% is expected in the next year compared to the current price of 114.5. Check the REDCARE PHARMACY NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 2.36B EUR. This makes RDC.DE a Mid Cap stock.
REDCARE PHARMACY NV (RDC.DE) currently has 2075 employees.
REDCARE PHARMACY NV (RDC.DE) has a support level at 114.49 and a resistance level at 115.53. Check the full technical report for a detailed analysis of RDC.DE support and resistance levels.
The Revenue of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 33.02% in the next year. Check the estimates tab for more information on the RDC.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RDC.DE does not pay a dividend.
REDCARE PHARMACY NV (RDC.DE) will report earnings on 2025-03-11, after the market close.
REDCARE PHARMACY NV (RDC.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.29).
ChartMill assigns a fundamental rating of 4 / 10 to RDC.DE. The financial health of RDC.DE is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.29. The EPS decreased by -29.7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.41% | ||
ROE | -4.86% | ||
Debt/Equity | 0.46 |
ChartMill assigns a Buy % Consensus number of 77% to RDC.DE. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of -91.9% and a revenue growth 33.02% for RDC.DE